Emtricitabine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Emtricitabine and local guidelines before prescribing.
Nucleoside analogue antiviral
Mechanism
Nucleoside reverse transcriptase inhibitor.
Uses
HIV infection and pre-exposure prophylaxis (with tenofovir).
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Headache, diarrhoea, nausea, skin discolouration, hepatitis B flare on stopping.
Interactions
Nephrotoxic drugs.
Contraindications and cautions
Hypersensitivity
Monitoring
Renal function, HBV
Pregnancy and breastfeeding
Acceptable
Renal and hepatic impairment
Reduce dose if CrCl below 30
Overdose and reversal
Supportive
Special advice
Check HBV status before stopping.
More from the textbook: uses, cautions and other points
- Tenofovir disoproxil / emtricitabine | PrEP (daily or event-based); kidney monitoring.
Gynaecology: Sexual health - Prevention: PrEP (tenofovir/emtricitabine - free on the NHS), PEP (within 72 hours, ideally within 24, for 28 days), condoms, treatment as prevention, antenatal screening and ART (vertical transmission <0.3%).
Microbiology: Virology - structure, replication and important viral infections - Tenofovir disoproxil with emtricitabine - routinely available free from NHS sexual health clinics in England (since 2020).
Gynaecology: Sexual health - NRTIs | Tenofovir (disoproxil or alafenamide), emtricitabine, lamivudine, abacavir | Tenofovir disoproxil - kidney tubular damage (Fanconi), bone loss (alafenamide less so); tenofovir, emtricitabine and lamivudine also treat hepatitis B (stopping can cause a hepatitis flare); abacavir - severe hypersensitivity in people with HLA-B*57:01 …
ID: HIV, viral hepatitis and blood-borne viruses - Usual regimen - tenofovir disoproxil–emtricitabine plus an integrase inhibitor (e.g. raltegravir).
ID: HIV, viral hepatitis and blood-borne viruses - Bictegravir–emtricitabine–tenofovir alafenamide | Common single-tablet HIV regimen; separate from antacids, iron, calcium; slight creatinine rise.
ID: HIV, viral hepatitis and blood-borne viruses - Tenofovir disoproxil | HIV and hepatitis B; kidney tubular damage, bone loss; PrEP with emtricitabine.
ID: HIV, viral hepatitis and blood-borne viruses - Tenofovir–emtricitabine + raltegravir | HIV PEP for 28 days, within 72 hours.
ID: HIV, viral hepatitis and blood-borne viruses
Where it is discussed in the book
- Gynaecology: Sexual health (2 mentions)
- ID: HIV, viral hepatitis and blood-borne viruses (5 mentions)
- Microbiology: Virology - structure, replication and important viral infections (3 mentions)